Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

This publication has 15 references indexed in Scilit:

• Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study
  Diabetes/Metabolism Research and Reviews, 2004
• Is Metformin Cardioprotective?
  Diabetes Care, 2003
• Oral antidiabetic treatment in patients with coronary disease: Time‐related increased mortality on combined glyburide/metformin therapy over a 7.7‐year follow‐up
  Clinical Cardiology, 2001
• Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study
  Diabetologia, 2000
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998
• Some answers, more controversy, from UKPDS
  The Lancet, 1998
• Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
  New England Journal of Medicine, 1998
• The diabetes audit and research in Tayside Scotland (darts) study: electronic record linkage to create a diabetes register
  BMJ, 1997
• Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?
  Diabetologia, 1996